Redian新闻
>
GUIDE FOR AUTHORS Cancer Translational Medicine
avatar
GUIDE FOR AUTHORS Cancer Translational Medicine# Biology - 生物学
b*y
1
先关掉了serve account, 过了两天申请bluebird. 显示can not approve it because
the existing serve account. 打电话过去, agent 找不出原因, 连线serve的agent,
最后说必须用和serve 同一个email 申请. finally go through. 几个小时以后收到
email说 can not verify your information. 再打电话, agent 还是找不出原因,
hold N 次以后, 说你要在serve account 关掉 30天以后才能申请 bluebird。 我气
死了, 让他找出term 给我。 又被hold 一次, 让我换个email 申请试, 竟然当时就
通过了。 那个agent 竟然说他们系统就是有时候能过有时候不过的, 不知道原因。
这叫什么事儿呀
avatar
a*t
2
INTRODUCTION
Cancer Translational Medicine provides rapid and efficient peer-review
publications on innovative cancer investigation or translational work
related to oncology and precision medicine. Contributions focusing on
systemic anticancer therapy including gene-therapy, immuno-therapy, and some
new bio-therapies, randomized trials (including negatives ones), top-level
guidelines, molecular pathology, bioinformatics, modern statistics, and
biotechnologies. Radiotherapy, chemotherapy, surgery and pediatrics
manuscripts can be considered if they display a clear interaction with one
of the fields above or are paradigm-shifting. Cancer epidemiology and
prevention, control is considered also.
PREPARATION
Article Types
Cancer Translational Medicine publishes material in the form of Editorial,
Original Article, Short Communication, Review, Mini Review, Hypothesis, Meta
Analysis, Case Report, Letter, and etc.
Editorials are invited from editorial board members. They should focus on
hotspots of cancer research in last two years. They should be no more than
16,000 characters (4 pages).
Original articles should present significant new information gathered from
basic research. They should report on novel and well-designed studies and
present a complete body of work. Conclusions should not be based on
unpublished work or preliminary summaries of data. Previous studies or
precedents should be clearly and completely referenced.
Short communications may report on early clinical data or discovery-based
studies that are not sufficiently developed for publication as Research
Articles but have the potential to make a significant impact in research
areas and/or patient care. They should be no more than 16,000 characters (4
pages).
Reviews provide authoritative, comprehensive overviews on timely subjects
geared toward the general cancer research community. These articles should
include the author's point of view on how the subject relates to the current
state of the field and how it could affect research and/or treatment. They
should be more than 16,000 characters (4 pages).
Mini reviews focus on hotspots of cancer research and summarize the results
in last two years. And research tendency can be forecasted. They should be
no more than 16,000 characters (4 pages).
Hypothesis articles may report on short presentations of original ideas and
new insights relating to cancer causes and prevention.
Meta-analyses must adhere to alternative guidelines appropriate to the study
design, and include the completed checklist and flow diagram to accompany
the main text. Authors must complete the appropriate reporting checklist not
only with page references, but also with sufficient text excerpted from the
manuscript to explain how they accomplished all applicable items.
Case reports can be considered for publication as Letters to the editor.
Letters are welcome and will be published if appropriate. They should be no
longer than 8,000 words and a maximum of five references; one table or
figure is acceptable if absolutely necessary. No abstract is required. (2
pages).
Lettersare for correspondence relating to previously published articles, and
only then within an appropriate time frame, or some kind of interesting
practice points, e.g. emerging side-effects of new drugs, rare diseases
where there is a real practice issue.
Article Structure
Original article: Abstract (structured with headings Aim, Methods, Results,
Conclusion), Introduction, Materials and Methods, Results, and Discussion.
Case report: Abstract (unstructured), Introduction, Case History, and
Discussion.
1. Title
Title must be informative, specific and short and not exceed 200 characters.
Title must be in boldface and capital case having a font size and font
style of 16 pt and Times New Romanrespectively. It must be followed by one
empty line.
2. Abstract
A concise and factual abstract is required. The abstract should state
briefly the purpose of theresearch, the principal results and major
conclusions. An abstract is often presented separately fromthe article, so
it must be able to stand alone.For Original articles, abstracts should give
a pertinent overview of the work. We strongly encourage authors to use the
following style of structured abstracts with headings: 1) Objective: Place
the question addressed in a broad context and highlight the purpose of the
study; 2) Methods: Describe briefly the main methods or treatments applied;
3) Results: Summarize the article's main findings; and 4) Conclusion:
Indicate the main conclusions or interpretations. The abstract should be an
objective representation of the article. It must not contain results which
are not presented and substantiated in the main text and should not
exaggerate the main conclusions. For review articles, abstract is good with
a paragraph format. Letters and editorials don’t need abstract.
3. Keywords
Provide 4-5 keywords identifying the subject of your article.
4. Introduction
State the objectives of the work and provide an adequate background,
avoiding a detailed literature survey or a summary of the results.
5. Materials and Methods
All important materials used along with their source shall be mentioned. The
main methods used shall be briefly described with appropriate reference.
New methods or substantially modified methods may be described in sufficient
detail. Methods in general use need not be described in detail. The
statistical method and the level of significance chosen shall be clearly
stated.
6. Results
Results should be clear and concise. The data should be statistically
analyzed and the level of significance stated. Data that is not
statistically significant need only to be mentioned in the text - no
illustration is necessary. All tables and figures must have a title or
caption and a legend to make them self-explanatory.
7. Discussion
This section should deal with the interpretation of results, convey how they
help increase current understanding of the problem and should be logical.
Unsupported hypothesis should be avoided. The Discussion should state the
possibilities the results uncover, hat need to be further explored.
8. Acknowledgements
Acknowledgements of people, grants, funds, etc. should be placed in a
separate section before the References.
9. References
References should be numbered consecutively in the order in which they are
first mentioned in the text (not in alphabetic order). Identify references
in text, tables, and legends by Arabic numerals in superscript with square
bracket after the punctuation marks. References cited only in tables or
figure legends should be numbered in accordance with the sequence
established by the first identification in the text of the particular table
or figure.
All authors’ names should be listed in the references. The names of
journals should be abbreviated according to the style used in Index Medicus.
Avoid using abstracts as references. Information from manuscripts submitted
but not accepted should be cited in the text as “unpublished observations
” with written permission from the source. Avoid citing a “personal
communication” unless it provides essential information not available from
a public source, in which case the name of the person and date of
communication should be cited in parentheses in the text.
The commonly cited types of references are listed below, for other types of
references please refer to ICMJE Guidelines http://www.nlm.nih.gov/bsd/uniform_requirements.html.
Standard journal articles
Gaur K, Kori ML, Tyagi LK, Singh V, Nema RK, Tripathi P. Licofelone-novel
analgesic and anti-inflammatory agent for osteoarthritis: an overview. J
Young Pharm 2009; 1(1): 67-71.
Both personal authors and organization as author
Vallancien G, Emberton M, Harving N, van Moorselaar RJ; Alf-One Study Group.
Sexual dysfunction in 1,274 European men suffering from lower urinary tract
symptoms. J Urol 2003;169:2257-61.
Books
Sherlock S, Dooley J. Diseases of the liver and billiary system. 9th ed.
Oxford: Blackwell Sci Pub; 1993. p. 258-96.
Chapter in a book
Meltzer PS, Kallioniemi A, Trent JM. Chromosome alterations in human solid
tumors. In: Vogelstein B, Kinzler KW, editors. The genetic basis of human
cancer. New York: McGraw-Hill; 2002. p. 93-113.
Article not in English (translate article tile into English and specify the
source language)
Zhang X, Xiong H, Ji TY, Zhang YH, Wang Y. Case report of anti-N-methyl-D-
aspartate receptor encephalitis in child. J Appl Clin Pediatr 2012;27:1903-7
. (in Chinese).
Abbreviations
Authors should follow internationally agreed rules especially those adopted
by the IUPAC-IUB Commission on Biochemical Nomenclature (CBN). The journal
will essentially follow the rules defined in the IUPAC Manua1 of symbols and
terminology for physico-chemical quantities and units.
10. Figures and Tables
 All figure files should be separately uploaded during submission.
 Figures must be provided at a sufficiently high resolution (
minimum 1,000 pixels width/height, or a resolution of 300 dpi or higher).
All Figure file formats are accepted. However, TIFF, JPEG, EPS and PDF files
are preferred.
 Tables and Figure legends should be provided at the end of the
text (following References) in a separate page.
 All Figures and Tables should have a short explanatory title and
a caption placed above it.
Please do not
 Supply files that are optimized for screen use (e.g., GIF, BMP,
PICT, WPG); these typically have a low number of pixels and limited set of
colors.
 Supply files that are too low in resolution.
 Submit graphics that are disproportionately large for the
content.
File Preparation
All manuscripts must be typed 1.5 spaced and in 12 pt Times New Roman.
Margins of at least 0.8 inch (2 cm) must be left on all sides. Manuscript
must be written in clear and concise English. The responsibility for all
aspects of manuscript preparation rests with the authors. Extensive changes
or rewriting of the manuscript will not be undertaken by the Editors.
First page file and article file should be prepared separately. For First
page file, cover latter, conflict of interest, source of support, author
information should be included. For article file, title, abstract, keywords,
full text, references, tables, and figure legends should be included.
Cover Letter
A cover letter must be included with each manuscript submission. It should
be concise and explain why the content of your paper is significant, placing
your findings in the context of existing work and why it fits the scope of
the journal. Please confirm that neither the manuscript nor any parts of its
content are currently under consideration or published in another journal.
Conflict of Interest
All authors are requested to disclose any actual or potential conflict of
interest including any financial, personal or other relationships with other
people or organizations within three years of beginning the submitted work
that could inappropriately influence, or be perceived to influence, their
work.
Ethics
When reporting experiments on human subjects, indicate whether the
procedures followed were in accordance with the ethical standards of the
responsible committee on human experimentation (institutional or regional)
or with the Helsinki Declaration (1964, amended in 1975, 1983, 1989, 1996
and 2000) of the World Medical Association, do not use patients’ names,
initials, or hospital numbers, especially in any illustrative material. When
reporting experiments on animals, indicate whether the institution’s or
the National Research Council’s guide for, or any national law on, the care
and use of laboratory animals was followed.
Authorship
Authorship criteria should be based only on substantial contributions to
each of the three components mentioned below: (1) concept and design of
study or acquisition of data or analysis and interpretation of data; (2)
drafting the article or revising it critically for important intellectual
content; (3) final approval of the version to be published.
If several institutions are listed on a manuscript, it should be clearly
indicated with which department and institution each author is affiliated by
using superscript numbers that correspond to each author’s affiliation.
Use the symbols 1, 2, 3, etc., as superscripts to relate the authors to the
corresponding address. The order of the authors should be based on the
relative contribution of the author towards the study and writing the
manuscript.
Authors’ full name should be given (First name + Middle name + Last name).
Once submitted, authors cannot be added or deleted and the order cannot be
changed also without written consent of all authors.
Author institutions
The complete name of department, institution, city, zip code, province/state
, and country should be given.
Correspondence
The corresponding author is responsible for communicating with the other
authors about revisions and final approval of the proofs. The name, title,
institution, address, and e-mail of the corresponding author should be given
. To have a prompt and better communication, providing an available
telephone is greatly appreciated.
SUBMISSION
To facilitate speedy and cost-effective submission of full manuscript, an
online submission via internet is being offered. For online submission,
please provide your complete manuscript in the form of single file
containing all the materials. Authors are required to proof read the word
file of their manuscript before submission and to submit their manuscripts
electronically by online manuscript managing system http://www.cancertm.com or http://www.journalonweb.com/ctm.
AFTER ACCEPTANCE
As long as the article is accepted for publication, it will be sent for
further processing. Later the author will receive a notice to final proof
the article. And the author is required to upload the corrected proof to the
system by the due date.
Copyright
Authors are asked to sign a copyright agreement upon acceptance of their
manuscript, before the publication. The Copyright Agreement form can be
downloaded from our website http://www.cancertm.com.
avatar
d*j
3
不能同时拥有serve和bluebird,考古
avatar
a*t
4
INTRODUCTION
Cancer Translational Medicine provides rapid and efficient peer-review
publications on innovative cancer investigation or translational work
related to oncology and precision medicine. Contributions focusing on
systemic anticancer therapy including gene-therapy, immuno-therapy, and some
new bio-therapies, randomized trials (including negatives ones), top-level
guidelines, molecular pathology, bioinformatics, modern statistics, and
biotechnologies. Radiotherapy, chemotherapy, surgery and pediatrics
manuscripts can be considered if they display a clear interaction with one
of the fields above or are paradigm-shifting. Cancer epidemiology and
prevention, control is considered also.
PREPARATION
Article Types
Cancer Translational Medicine publishes material in the form of Editorial,
Original Article, Short Communication, Review, Mini Review, Hypothesis, Meta
Analysis, Case Report, Letter, and etc.
Editorials are invited from editorial board members. They should focus on
hotspots of cancer research in last two years. They should be no more than
16,000 characters (4 pages).
Original articles should present significant new information gathered from
basic research. They should report on novel and well-designed studies and
present a complete body of work. Conclusions should not be based on
unpublished work or preliminary summaries of data. Previous studies or
precedents should be clearly and completely referenced.
Short communications may report on early clinical data or discovery-based
studies that are not sufficiently developed for publication as Research
Articles but have the potential to make a significant impact in research
areas and/or patient care. They should be no more than 16,000 characters (4
pages).
Reviews provide authoritative, comprehensive overviews on timely subjects
geared toward the general cancer research community. These articles should
include the author's point of view on how the subject relates to the current
state of the field and how it could affect research and/or treatment. They
should be more than 16,000 characters (4 pages).
Mini reviews focus on hotspots of cancer research and summarize the results
in last two years. And research tendency can be forecasted. They should be
no more than 16,000 characters (4 pages).
Hypothesis articles may report on short presentations of original ideas and
new insights relating to cancer causes and prevention.
Meta-analyses must adhere to alternative guidelines appropriate to the study
design, and include the completed checklist and flow diagram to accompany
the main text. Authors must complete the appropriate reporting checklist not
only with page references, but also with sufficient text excerpted from the
manuscript to explain how they accomplished all applicable items.
Case reports can be considered for publication as Letters to the editor.
Letters are welcome and will be published if appropriate. They should be no
longer than 8,000 words and a maximum of five references; one table or
figure is acceptable if absolutely necessary. No abstract is required. (2
pages).
Lettersare for correspondence relating to previously published articles, and
only then within an appropriate time frame, or some kind of interesting
practice points, e.g. emerging side-effects of new drugs, rare diseases
where there is a real practice issue.
Article Structure
Original article: Abstract (structured with headings Aim, Methods, Results,
Conclusion), Introduction, Materials and Methods, Results, and Discussion.
Case report: Abstract (unstructured), Introduction, Case History, and
Discussion.
1. Title
Title must be informative, specific and short and not exceed 200 characters.
Title must be in boldface and capital case having a font size and font
style of 16 pt and Times New Romanrespectively. It must be followed by one
empty line.
2. Abstract
A concise and factual abstract is required. The abstract should state
briefly the purpose of theresearch, the principal results and major
conclusions. An abstract is often presented separately fromthe article, so
it must be able to stand alone.For Original articles, abstracts should give
a pertinent overview of the work. We strongly encourage authors to use the
following style of structured abstracts with headings: 1) Objective: Place
the question addressed in a broad context and highlight the purpose of the
study; 2) Methods: Describe briefly the main methods or treatments applied;
3) Results: Summarize the article's main findings; and 4) Conclusion:
Indicate the main conclusions or interpretations. The abstract should be an
objective representation of the article. It must not contain results which
are not presented and substantiated in the main text and should not
exaggerate the main conclusions. For review articles, abstract is good with
a paragraph format. Letters and editorials don’t need abstract.
3. Keywords
Provide 4-5 keywords identifying the subject of your article.
4. Introduction
State the objectives of the work and provide an adequate background,
avoiding a detailed literature survey or a summary of the results.
5. Materials and Methods
All important materials used along with their source shall be mentioned. The
main methods used shall be briefly described with appropriate reference.
New methods or substantially modified methods may be described in sufficient
detail. Methods in general use need not be described in detail. The
statistical method and the level of significance chosen shall be clearly
stated.
6. Results
Results should be clear and concise. The data should be statistically
analyzed and the level of significance stated. Data that is not
statistically significant need only to be mentioned in the text - no
illustration is necessary. All tables and figures must have a title or
caption and a legend to make them self-explanatory.
7. Discussion
This section should deal with the interpretation of results, convey how they
help increase current understanding of the problem and should be logical.
Unsupported hypothesis should be avoided. The Discussion should state the
possibilities the results uncover, hat need to be further explored.
8. Acknowledgements
Acknowledgements of people, grants, funds, etc. should be placed in a
separate section before the References.
9. References
References should be numbered consecutively in the order in which they are
first mentioned in the text (not in alphabetic order). Identify references
in text, tables, and legends by Arabic numerals in superscript with square
bracket after the punctuation marks. References cited only in tables or
figure legends should be numbered in accordance with the sequence
established by the first identification in the text of the particular table
or figure.
All authors’ names should be listed in the references. The names of
journals should be abbreviated according to the style used in Index Medicus.
Avoid using abstracts as references. Information from manuscripts submitted
but not accepted should be cited in the text as “unpublished observations
” with written permission from the source. Avoid citing a “personal
communication” unless it provides essential information not available from
a public source, in which case the name of the person and date of
communication should be cited in parentheses in the text.
The commonly cited types of references are listed below, for other types of
references please refer to ICMJE Guidelines http://www.nlm.nih.gov/bsd/uniform_requirements.html.
Standard journal articles
Gaur K, Kori ML, Tyagi LK, Singh V, Nema RK, Tripathi P. Licofelone-novel
analgesic and anti-inflammatory agent for osteoarthritis: an overview. J
Young Pharm 2009; 1(1): 67-71.
Both personal authors and organization as author
Vallancien G, Emberton M, Harving N, van Moorselaar RJ; Alf-One Study Group.
Sexual dysfunction in 1,274 European men suffering from lower urinary tract
symptoms. J Urol 2003;169:2257-61.
Books
Sherlock S, Dooley J. Diseases of the liver and billiary system. 9th ed.
Oxford: Blackwell Sci Pub; 1993. p. 258-96.
Chapter in a book
Meltzer PS, Kallioniemi A, Trent JM. Chromosome alterations in human solid
tumors. In: Vogelstein B, Kinzler KW, editors. The genetic basis of human
cancer. New York: McGraw-Hill; 2002. p. 93-113.
Article not in English (translate article tile into English and specify the
source language)
Zhang X, Xiong H, Ji TY, Zhang YH, Wang Y. Case report of anti-N-methyl-D-
aspartate receptor encephalitis in child. J Appl Clin Pediatr 2012;27:1903-7
. (in Chinese).
Abbreviations
Authors should follow internationally agreed rules especially those adopted
by the IUPAC-IUB Commission on Biochemical Nomenclature (CBN). The journal
will essentially follow the rules defined in the IUPAC Manua1 of symbols and
terminology for physico-chemical quantities and units.
10. Figures and Tables
 All figure files should be separately uploaded during submission.
 Figures must be provided at a sufficiently high resolution (
minimum 1,000 pixels width/height, or a resolution of 300 dpi or higher).
All Figure file formats are accepted. However, TIFF, JPEG, EPS and PDF files
are preferred.
 Tables and Figure legends should be provided at the end of the
text (following References) in a separate page.
 All Figures and Tables should have a short explanatory title and
a caption placed above it.
Please do not
 Supply files that are optimized for screen use (e.g., GIF, BMP,
PICT, WPG); these typically have a low number of pixels and limited set of
colors.
 Supply files that are too low in resolution.
 Submit graphics that are disproportionately large for the
content.
File Preparation
All manuscripts must be typed 1.5 spaced and in 12 pt Times New Roman.
Margins of at least 0.8 inch (2 cm) must be left on all sides. Manuscript
must be written in clear and concise English. The responsibility for all
aspects of manuscript preparation rests with the authors. Extensive changes
or rewriting of the manuscript will not be undertaken by the Editors.
First page file and article file should be prepared separately. For First
page file, cover latter, conflict of interest, source of support, author
information should be included. For article file, title, abstract, keywords,
full text, references, tables, and figure legends should be included.
Cover Letter
A cover letter must be included with each manuscript submission. It should
be concise and explain why the content of your paper is significant, placing
your findings in the context of existing work and why it fits the scope of
the journal. Please confirm that neither the manuscript nor any parts of its
content are currently under consideration or published in another journal.
Conflict of Interest
All authors are requested to disclose any actual or potential conflict of
interest including any financial, personal or other relationships with other
people or organizations within three years of beginning the submitted work
that could inappropriately influence, or be perceived to influence, their
work.
Ethics
When reporting experiments on human subjects, indicate whether the
procedures followed were in accordance with the ethical standards of the
responsible committee on human experimentation (institutional or regional)
or with the Helsinki Declaration (1964, amended in 1975, 1983, 1989, 1996
and 2000) of the World Medical Association, do not use patients’ names,
initials, or hospital numbers, especially in any illustrative material. When
reporting experiments on animals, indicate whether the institution’s or
the National Research Council’s guide for, or any national law on, the care
and use of laboratory animals was followed.
Authorship
Authorship criteria should be based only on substantial contributions to
each of the three components mentioned below: (1) concept and design of
study or acquisition of data or analysis and interpretation of data; (2)
drafting the article or revising it critically for important intellectual
content; (3) final approval of the version to be published.
If several institutions are listed on a manuscript, it should be clearly
indicated with which department and institution each author is affiliated by
using superscript numbers that correspond to each author’s affiliation.
Use the symbols 1, 2, 3, etc., as superscripts to relate the authors to the
corresponding address. The order of the authors should be based on the
relative contribution of the author towards the study and writing the
manuscript.
Authors’ full name should be given (First name + Middle name + Last name).
Once submitted, authors cannot be added or deleted and the order cannot be
changed also without written consent of all authors.
Author institutions
The complete name of department, institution, city, zip code, province/state
, and country should be given.
Correspondence
The corresponding author is responsible for communicating with the other
authors about revisions and final approval of the proofs. The name, title,
institution, address, and e-mail of the corresponding author should be given
. To have a prompt and better communication, providing an available
telephone is greatly appreciated.
SUBMISSION
To facilitate speedy and cost-effective submission of full manuscript, an
online submission via internet is being offered. For online submission,
please provide your complete manuscript in the form of single file
containing all the materials. Authors are required to proof read the word
file of their manuscript before submission and to submit their manuscripts
electronically by online manuscript managing system http://www.cancertm.com or http://www.journalonweb.com/ctm.
AFTER ACCEPTANCE
As long as the article is accepted for publication, it will be sent for
further processing. Later the author will receive a notice to final proof
the article. And the author is required to upload the corrected proof to the
system by the due date.
Copyright
Authors are asked to sign a copyright agreement upon acceptance of their
manuscript, before the publication. The Copyright Agreement form can be
downloaded from our website http://www.cancertm.com.
avatar
t*a
5
patpat
我关了serve之后换bb瞬间就批了,事先考古发现要用同一个邮箱的。。。(有serve的
时候也是换了邮箱申bb的)
或许他家系统有bug,一旦换邮箱触发了就会导致后面的问题。
事先考古总归是好习惯。

because
,

【在 b*y 的大作中提到】
: 先关掉了serve account, 过了两天申请bluebird. 显示can not approve it because
: the existing serve account. 打电话过去, agent 找不出原因, 连线serve的agent,
: 最后说必须用和serve 同一个email 申请. finally go through. 几个小时以后收到
: email说 can not verify your information. 再打电话, agent 还是找不出原因,
: hold N 次以后, 说你要在serve account 关掉 30天以后才能申请 bluebird。 我气
: 死了, 让他找出term 给我。 又被hold 一次, 让我换个email 申请试, 竟然当时就
: 通过了。 那个agent 竟然说他们系统就是有时候能过有时候不过的, 不知道原因。
: 这叫什么事儿呀

avatar
a*t
6
欢迎投稿。
avatar
e*n
7
这俩哪个好啊,为什么我的serve一直审核啊

patpat我关了serve之后换bb瞬间就批了,事先考古发现要用同一个邮箱的。。。(有
serve的时候也是换了邮箱申bb的)或许他家系统有bug,一旦换邮箱触发了就会导致后
面........

【在 t*******a 的大作中提到】
: patpat
: 我关了serve之后换bb瞬间就批了,事先考古发现要用同一个邮箱的。。。(有serve的
: 时候也是换了邮箱申bb的)
: 或许他家系统有bug,一旦换邮箱触发了就会导致后面的问题。
: 事先考古总归是好习惯。
:
: because
: ,

avatar
t*a
8
你几天了?是要好几天的。。。很慢
哪个好看你打算怎么使用了吧。
serve在三月份前可以免费cash out credit card和gift cards(当credit card load
进去),时不时还有些蚊子肉。。。
bluebird可以作为中转让你在不能用cc的地方用cc来pay,比如mortgage, auto loan
至于具体怎么做,板上有很多讨论的

【在 e*********n 的大作中提到】
: 这俩哪个好啊,为什么我的serve一直审核啊
:
: patpat我关了serve之后换bb瞬间就批了,事先考古发现要用同一个邮箱的。。。(有
: serve的时候也是换了邮箱申bb的)或许他家系统有bug,一旦换邮箱触发了就会导致后
: 面........

avatar
e*n
9
review了快2周了,不知道跟圣诞新年假有没有关系

你几天了?是要好几天的。。。很慢哪个好看你打算怎么使用了吧。serve在三月份前
可以免费cash out credit card和gift cards(当credit card........

【在 t*******a 的大作中提到】
: 你几天了?是要好几天的。。。很慢
: 哪个好看你打算怎么使用了吧。
: serve在三月份前可以免费cash out credit card和gift cards(当credit card load
: 进去),时不时还有些蚊子肉。。。
: bluebird可以作为中转让你在不能用cc的地方用cc来pay,比如mortgage, auto loan
: 至于具体怎么做,板上有很多讨论的

avatar
e*n
10
蚊子肉是什么意思?

你几天了?是要好几天的。。。很慢哪个好看你打算怎么使用了吧。serve在三月份前
可以免费cash out credit card和gift cards(当credit card........

【在 t*******a 的大作中提到】
: 你几天了?是要好几天的。。。很慢
: 哪个好看你打算怎么使用了吧。
: serve在三月份前可以免费cash out credit card和gift cards(当credit card load
: 进去),时不时还有些蚊子肉。。。
: bluebird可以作为中转让你在不能用cc的地方用cc来pay,比如mortgage, auto loan
: 至于具体怎么做,板上有很多讨论的

avatar
b*y
11
我就是关了serve 以后才申请de

【在 d**j 的大作中提到】
: 不能同时拥有serve和bluebird,考古
avatar
b*y
12
有道理,我第一次申请的时候agent也是让用同一个邮箱。搞不懂的是后来,用不同的
邮箱才申请成了

【在 t*******a 的大作中提到】
: patpat
: 我关了serve之后换bb瞬间就批了,事先考古发现要用同一个邮箱的。。。(有serve的
: 时候也是换了邮箱申bb的)
: 或许他家系统有bug,一旦换邮箱触发了就会导致后面的问题。
: 事先考古总归是好习惯。
:
: because
: ,

avatar
c*7
13
关了serve,用相同的email申请bluebird,出现错误。换email还是通不过。
avatar
b*y
14
先关掉了serve account, 过了两天申请bluebird. 显示can not approve it because
the existing serve account. 打电话过去, agent 找不出原因, 连线serve的agent,
最后说必须用和serve 同一个email 申请. finally go through. 几个小时以后收到
email说 can not verify your information. 再打电话, agent 还是找不出原因,
hold N 次以后, 说你要在serve account 关掉 30天以后才能申请 bluebird。 我气
死了, 让他找出term 给我。 又被hold 一次, 让我换个email 申请试, 竟然当时就
通过了。 那个agent 竟然说他们系统就是有时候能过有时候不过的, 不知道原因。
这叫什么事儿呀
avatar
d*j
15
不能同时拥有serve和bluebird,考古
avatar
t*a
16
patpat
我关了serve之后换bb瞬间就批了,事先考古发现要用同一个邮箱的。。。(有serve的
时候也是换了邮箱申bb的)
或许他家系统有bug,一旦换邮箱触发了就会导致后面的问题。
事先考古总归是好习惯。

because
,

【在 b*y 的大作中提到】
: 先关掉了serve account, 过了两天申请bluebird. 显示can not approve it because
: the existing serve account. 打电话过去, agent 找不出原因, 连线serve的agent,
: 最后说必须用和serve 同一个email 申请. finally go through. 几个小时以后收到
: email说 can not verify your information. 再打电话, agent 还是找不出原因,
: hold N 次以后, 说你要在serve account 关掉 30天以后才能申请 bluebird。 我气
: 死了, 让他找出term 给我。 又被hold 一次, 让我换个email 申请试, 竟然当时就
: 通过了。 那个agent 竟然说他们系统就是有时候能过有时候不过的, 不知道原因。
: 这叫什么事儿呀

avatar
e*n
17
这俩哪个好啊,为什么我的serve一直审核啊

patpat我关了serve之后换bb瞬间就批了,事先考古发现要用同一个邮箱的。。。(有
serve的时候也是换了邮箱申bb的)或许他家系统有bug,一旦换邮箱触发了就会导致后
面........

【在 t*******a 的大作中提到】
: patpat
: 我关了serve之后换bb瞬间就批了,事先考古发现要用同一个邮箱的。。。(有serve的
: 时候也是换了邮箱申bb的)
: 或许他家系统有bug,一旦换邮箱触发了就会导致后面的问题。
: 事先考古总归是好习惯。
:
: because
: ,

avatar
t*a
18
你几天了?是要好几天的。。。很慢
哪个好看你打算怎么使用了吧。
serve在三月份前可以免费cash out credit card和gift cards(当credit card load
进去),时不时还有些蚊子肉。。。
bluebird可以作为中转让你在不能用cc的地方用cc来pay,比如mortgage, auto loan
至于具体怎么做,板上有很多讨论的

【在 e*********n 的大作中提到】
: 这俩哪个好啊,为什么我的serve一直审核啊
:
: patpat我关了serve之后换bb瞬间就批了,事先考古发现要用同一个邮箱的。。。(有
: serve的时候也是换了邮箱申bb的)或许他家系统有bug,一旦换邮箱触发了就会导致后
: 面........

avatar
e*n
19
review了快2周了,不知道跟圣诞新年假有没有关系

你几天了?是要好几天的。。。很慢哪个好看你打算怎么使用了吧。serve在三月份前
可以免费cash out credit card和gift cards(当credit card........

【在 t*******a 的大作中提到】
: 你几天了?是要好几天的。。。很慢
: 哪个好看你打算怎么使用了吧。
: serve在三月份前可以免费cash out credit card和gift cards(当credit card load
: 进去),时不时还有些蚊子肉。。。
: bluebird可以作为中转让你在不能用cc的地方用cc来pay,比如mortgage, auto loan
: 至于具体怎么做,板上有很多讨论的

avatar
e*n
20
蚊子肉是什么意思?

你几天了?是要好几天的。。。很慢哪个好看你打算怎么使用了吧。serve在三月份前
可以免费cash out credit card和gift cards(当credit card........

【在 t*******a 的大作中提到】
: 你几天了?是要好几天的。。。很慢
: 哪个好看你打算怎么使用了吧。
: serve在三月份前可以免费cash out credit card和gift cards(当credit card load
: 进去),时不时还有些蚊子肉。。。
: bluebird可以作为中转让你在不能用cc的地方用cc来pay,比如mortgage, auto loan
: 至于具体怎么做,板上有很多讨论的

avatar
b*y
21
我就是关了serve 以后才申请de

【在 d**j 的大作中提到】
: 不能同时拥有serve和bluebird,考古
avatar
b*y
22
有道理,我第一次申请的时候agent也是让用同一个邮箱。搞不懂的是后来,用不同的
邮箱才申请成了

【在 t*******a 的大作中提到】
: patpat
: 我关了serve之后换bb瞬间就批了,事先考古发现要用同一个邮箱的。。。(有serve的
: 时候也是换了邮箱申bb的)
: 或许他家系统有bug,一旦换邮箱触发了就会导致后面的问题。
: 事先考古总归是好习惯。
:
: because
: ,

avatar
c*7
23
关了serve,用相同的email申请bluebird,出现错误。换email还是通不过。
avatar
c*e
24
I am confused now, I should use the same email address or different one?
相关阅读
logo
联系我们隐私协议©2024 redian.news
Redian新闻
Redian.news刊载任何文章,不代表同意其说法或描述,仅为提供更多信息,也不构成任何建议。文章信息的合法性及真实性由其作者负责,与Redian.news及其运营公司无关。欢迎投稿,如发现稿件侵权,或作者不愿在本网发表文章,请版权拥有者通知本网处理。